Plus, news about Salspera and Hoba Therapeutics:

🥊 Bimzelx bests Skyrizi in psoriatic arthritis trial: UCB said its IL-17A/F drug Bimzelx showed “statistically significant superiority” over AbbVie’s IL-23 blockbuster Skyrizi …

Subscribe for Updates

Copyright 2025 dijee Intelligence Ltd.   dijee Intelligence Ltd. is a private limited company registered in England and Wales at Media House, Sopers Road, Cuffley, Hertfordshire, EN6 4RY, UK registration number 16808844